Walmart to alter opioid prescription policies at its pharmacies
Date: 2018-05-08   Author: Ojaswita Kutepatil  Category: #news

In a bid to curb opioid misuse and abuse, Walmart Inc., has announced that it will only fill first-time opioid prescriptions for acute pain to seven days or even less across the United States. Reportedly, the initiative will be commenced within 60 days and comes on the heels of the rising number of healthcare entities tightening the rules surrounding the filing of opioid prescriptions.

Sources reveal that pharmacies, beginning 1st January 2020, will be restricting the dosage of opioids to not more than 50 MMEs (morphine milligrams equivalent) per day and will require online prescriptions for controlled substances. The e-prescriptions are deemed to minimize error and prevent prescription frauds.  

Marybeth Hays, Walmart’s executive VP of health and wellness and consumables, was quoted stating that the company is taking action in the fight against the nation’s opioid epidemic. In an effort to continue to be a part of the solution, Walmart is introducing new programs, tools and policies that will be aimed at addressing the critical issues faced by the patients & communities.

Reliable reports claim that the initiatives will also be applicable to Sam’s Club Pharmacies, which is owned by Walmart. Several other companies have also been making similar efforts to help mitigate the opioid epidemic.

As per industry analysts, these proposals have disclosed that limitations are important to lower the number of painkillers that are available to be unlawfully diverted, stem overprescribing, and lower the potential for addiction.

Opioid overdose crisis and the proposal for its limits have garnered significant support from several shareholders, owing to which a bill in the Senate will be restricting the initial prescriptions for acute pain to 3 days.

Meanwhile, the AMA (American Medical Association) has countered that the limits over opioid dosage & supply are arbitrary and believes that the decision needs to be left between the physician and the patient.



About Author


Ojaswita Kutepatil

Ojaswita Kutepatil

Ojaswita Kutepatil, a mechanical engineer by qualification, worked as a BDE and Technical Engineer before switching her profession to content writing. Currently, she works at AlgosOnline. as an Content writer, where she pens down write-ups pertaining to the market res...

Read More

More from Ojaswita


Post Recommendents

IHH Healthcare wins takeover bid of Fortis for RM2.34 billion
Author: Pankaj Singh

After winning a month-long war against domestic and international bidders, India’s Fortis Healthcare Ltd has unveiled that it has accepted an investment offer from IHH Healthcare Bhd. According to the sources fam...


Grab launches GrabFresh, penetrates on-demand grocery delivery market
Author: Saipriya Iyer

Grab a technology based company in Singapore, reportedly announced that it has decided to mark its presence in the on-demand grocery delivery industry. The firm plans to introduce its new app called GrabFresh in partne...


China looking to buy a majority stake in British nuclear power plants
Author: Pankaj Singh

China General Nuclear Power Group (CGN) is rumored to be interested in purchasing a majority stake in eight nuclear power plants in Britain, a deal that could be valued at around £4 billion (HK$41.71 billion). Th...